CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.75
-0.25 (-2.28%)
Jul 29, 2025, 4:35 PM GMT+1
CRISM Therapeutics Revenue
In the year 2024, CRISM Therapeutics had annual revenue of 25.00K GBP, down -44.44%.
Revenue
25.00K
Revenue Growth
-44.44%
P/S Ratio
171.84
Revenue / Employee
6.25K
Employees
4
Market Cap
4.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.00K | -20.00K | -44.44% |
| Dec 31, 2023 | 45.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
CRISM Therapeutics News
- 4 weeks ago - AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence - The Armchair Trader
- 3 months ago - AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy - The Armchair Trader